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Abstract
Researchers at the University of Southern Queensland have developed a personal UV
dosimeter that can quantitatively assess high exposure solar UVA exposures. The
chemical polyphenylene oxide has been previously reported on its ability to measure
high UVB exposures. This current research has found that polyphenylene oxide, cast5
in thin film form, is responsive to both the UVA and UVB parts of the solar spectrum.
Further to this, the UVB wavelengths were filtered out with the use of mylar. This
combined system responded to the UVA wavelengths only and underwent a change
in optical absorbance as a result of UVA exposure. Preliminary results indicate that
this UVA dosimeter saturates steadily when exposed to sunlight and can measure ex-10
posures of more than 20MJ/m
2
of solar UVA radiation with an uncertainty level of no
more than ±5%.
1 Introduction
Exposure to UV radiation is known to be a causative factor in the induction of skin
cancers and other sun-related disorders. Most acute responses of humans to UV15
exposure occur as a result of UVB (280 to 315 nm) exposures, as these wavelengths
are highly effective in creating a human biological response. However, this does not
mean that UVA radiation has no impact on human UV exposures and health. UVA can
cause erythema in human skin, yet, the exposures required to create such a response
is much larger than UVB radiation. UVA radiation penetrates much deeper into human20
skin tissue than UVB, resulting in impacts that are not as acute, taking many years to
manifest. Past research has shown that UVA (315 to 400 nm) plays a significant role
in human skin carcinogenesis, immune suppression, DNA damage, photoageing and
wrinkling (Agar et al., 2004; Moan et al., 1999; Garland et al., 2003). Skin cancer is
considered the most common malignant neoplasm in Australia and the USA (Kricker25
and Armstrong, 1996; Glanz and Mayer, 2005; NCI, 2006). Over 1,600 Australians
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die from skin cancer each year and a further 380,000 Australians are treated for skin
cancer each year (NCCI, 2003; AIHW, 2004; AIHW, 2005). Estimates put direct health
care costs of all types of skin cancer in Australia in the region of $734.9 million per year,
with the indirect costs in the form of sick leave and foregone earnings in the region of
$1.395 billion per year (Armstrong, 1995). As a result, it is essential to decrease the5
amount of exposure to damaging solar UV radiation that the population experiences.
This requires methods to understand the solar UV radiation environment that humans
live in. Quantification of the individual level of solar UV radiation exposure requires
personal dosimetry due to changes in the position of people compared to the radiation
source.10
Commonly used UV chemical dosimeters are polysulphone and phenothiazine. Phe-
nothiazine has been used for measuring UVA wavelengths in various environments
(Parisi et al., 2005). However, phenothiazine only has the capability to record a cu-
mulative exposure over a small time period, usually three to four hours. This small
dynamic range greatly reduces the amount of time over which a UVA exposure can be15
measured in the field. Therefore, a chemical dosimeter that is capable of measuring
large amounts of UVA radiation over a long time period would be very useful. Research
conducted by Davis et al. (1976) showed that Poly (2,6-dimethyl-1, 4-phenylene oxide)
(PPO) film could be employed to measure high levels of UV exposure. Further research
found PPO to be ideal for this purpose as it would allow for unattended measurements20
to be made at various locations over extensive amounts of time with high levels of ac-
curacy when compared against radiometric measurements (Davis et al., 1981; Berre
and Lala, 1989; Lester et al., 2003). Schouten et al. (2007) found that PPO has a
progressively increasing response to UVA wavelengths over time. PPO dosimeters
have been utilised in the measurement of global UV exposures, however, they have25
not been used to measure high exposure solar UVA exposures. The aim of this paper
was to extend the previous research that has employed PPO dosimeters for the mea-
surement of solar UVB and erythemal exposures to investigate the suitability of PPO
for the measurement of high exposure solar UVA irradiances.
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2 Materials and methods
2.1 PPO
PPO film of approximately 40µm thickness was attached with adhesive tape to a plas-
tic holder. The holders for the dosimeters were 3×3 cm in size and fabricated from thin
polyvinylchloride with an aperture of approximately 1.2×1.6 cm (Fig. 1). A UV/visible5
spectrophotometer (model 1601, Shimadzu Co., Kyoto, Japan) was used to measure
the pre and post exposure absorbance of the dosimeter. The uncertainty range for op-
tical absorbance measurements in the spectrophotometer has been stated as ±0.002
by the manufacturer. PPO is responsive to both the UVA and UVB part of the solar
spectrum, therefore the UVB wavelengths were filtered by placing 120µm thick my-10
lar film (Cadillac Plastics, Australia) on top of the PPO film. For each dosimeter, the
change in optical absorbance (∆A320) due to UV exposure was measured at 320 nm
(with mylar removed) at four different sites over the dosimeter in order to minimise
any errors due to any possible minor variations in the PPO film over the size of the
dosimeter. The change in optical absorbance was measured at 320 nm as previous15
studies have shown that this is the wavelength where the greatest overall UV energy
induced change occurs (Lester et al., 2003; Schouten et al., 2007). The post expo-
sure absorbance was measured at a standardized time following exposure to minimize
any error associated with the post exposure “dark reaction” of the PPO (Lester et al.,
2003; Schouten et al., 2007). Lester et al. (2003) has shown previously that the PPO20
dosimeter is not a temperature dependent system, so fluctuations in temperature over
the exposure time period will not have any influence upon the subsequent measure-
ment error.
2.2 Calibration
The dosimeters were calibrated for UVA exposures by exposing a series of dosimeters25
on a horizontal plane, to relatively clear sky solar UV from approximately 0800 to 1600h
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Australian Eastern Standard Time (EST) for a total of 22 days. These calibrations ran
over the months of April and May at a subtropical Southern Hemisphere site at the
University of Southern Queensland, Toowoomba, Australia (27.6
◦
S, 151.9
◦
E, altitude
693m). The solar zenith angle (SZA) ranged from 30
◦
to 75
◦
. The PPO dosimeters
were calibrated on a horizontal plane with a UVA meter (501 Biometer, Solar Light5
Co., Philadelphia, USA). The UVA meter was calibrated against a scanning spectrora-
diometer (Bentham Instruments, Ltd, Reading, UK). The spectroradiometer is based on
a double grating monochromator, a UV sensitive detector and amplifier with software
variable gain provided by a programmable high voltage power supply. The interior
of the spectroradiometer enclosure is temperature stabilised to 23.0± 0.5
◦
C, using a10
Peltier heater/cooler unit. The input optics of the spectroradiometer are provided by a
PTFE (polytetrafluoro ethylene) diffuser and connected by an optical fibre to the input
slit of the monochromator. The spectroradiometer is programmed to start scanning
the global UV spectrum in 0.5 nm increments from dawn, and thereafter every 10min
till dusk. The instrument is wavelength calibrated to the UV spectral lines of a mer-15
cury lamp and irradiance calibrated to a 150Watt quartz tungsten halogen lamp with
calibration traceable to the National Physical Laboratory, UK standard.
To produce the calibration curve, the UVA exposure (MJ/m
2
) was measured over spe-
cific intervals with the UVA meter. This measurement was then calibrated to the scan-
ning spectroradiometer by employing a transfer equation with a calculated R
2
value20
of no less than 0.99. After each interval, the ∆A320 for a single PPO dosimeter was
measured by the spectrophotometer to provide a single data point, where ∆A320 was
calculated by the following
∆A320=A
FINAL
320
−AINITIAL
320
where A
FINAL
320 is the final optical absorbance measurement after exposure taken at25
320 nm and A
INITIAL
320 is the initial absorbance measurement before exposure taken at
320 nm. After the absorbency was measured, the dosimeter was then removed from
the batch.
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2.3 Reproducibility
To test the reproducibility of the dosimeters for the measurement of solar UVA, ten
dosimeters (with mylar filter) were exposed simultaneously to solar UV over a three
hour period on a horizontal plane. These exposures were conducted on an unshaded
sports oval in spring for clear sky conditions.5
3 Results
3.1 Filtered exposures
The spectral transmission of the mylar film was measured pre-exposure and post-
exposure to solar UV to test for any significant changes. The change in spectral
transmission of the mylar film is provided in Fig. 2. The maximum change was ap-10
proximately 13% from 331 to 337 nm. The change in absorbency of the PPO film pre-
and post-exposure is provided in Fig. 3.
3.2 Calibration
The calibration of the PPO dosimeters for solar UVA exposure is shown in Fig. 4. The
data points are the averages of the four ∆A’s measured for each dosimeter and the15
error bars on the x-axis values are the standard deviation of the four measurements. A
power law was fitted to the calibration data with the form of:
UVA=11.7(x
0.51
)MJ/m
2
where x is the change in absorbency. The resulting R
2
for
the calibration was greater than 0.99.
3.3 Reproducibility20
For reproducibility tests, ten dosimeters were placed on a horizontal plane and exposed
to solar UV. All dosimeters received the same exposure of solar UV producing a mean
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∆A320 of 0.598 with a standard deviation of no more than 3% and a coefficient of
variation equal to approximately 5%. This variation may be due minor variations over
the surface of the sheet of PPO film from which the dosimeters were fabricated and the
influence of dust particles that accumulated on the surface of the dosimeters during
the exposure period.5
4 Discussion
Preliminary results indicate that this UVA dosimeter saturates reasonably slowly when
exposed to sunlight and can measure exposures of more than 20MJ/m
2
of solar UVA
radiation with an uncertainty level of no more than ±5%. The size and lightweight
properties of the dosimeter means that it can be attached to any anatomical site on10
the human body in different environments such as underneath shade or in a vehicle
in order to measure the solar UVA exposures with a level of ease, simplicity and cost-
effectiveness not associated with counterpart radiometric measurements. The usage
of the dosimeter requires the calibration against a calibrated UVA meter. The profile
of the calibration curve will vary with the season and this can be overcome by cali-15
brating the dosimeter in the season that it will be employed to measure the solar UVA
exposures.
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Figure 1. A sample PPO dosimeter with the mylar film
Fig. 1. A sample PPO dosimeter with the mylar film attachment.
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Fig. 2. The spectral transmission of mylar film before and after a total solar UVA exposure of
20MJ/m
2
.
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Fig. 3. The absorption spectrum of PPO before and after a total solar UVA exposure of
20MJ/m
2
.
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Fig. 4. Calibration curve of PPO for UVA exposures. The error bars represent the standard
deviation in each series of absorbency measurements.
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